Home
Bereskin & Parr LLP
Nyrie Israelian
Nyrie Israelian
Bereskin & Parr LLP
2022 Year In Review: Life Sciences
23 Feb 2023 | Canada
A Coming Of Age For The Federal Court Summary Trial In Intellectual Property Litigation
07 Dec 2022 | Canada
PMPRB Regulations Saga Coming To An End? New Draft Guidelines Issued
13 Nov 2022 | Canada
Federal Court Sets Aside Minister Of Health's Approval Of RUZURGI For The Second Time Over Data Protection Dispute
03 Jun 2022 | Canada
Canada Drops Its Most Controversial Patented Drug Pricing Amendments
25 Apr 2022 | Canada
Supreme Court Of Canada Takes A Pass On Patented Drug Price Dispute
05 Apr 2022 | Canada
Federal Court Interprets Patent Act Amendments To Prior User Rights Provisions
09 Mar 2022 | Canada
2021 Year In Review: IP Litigation
02 Mar 2022 | Canada
Proposed Canadian Drug Pricing Rules Delayed By Feds And Battered By Courts
01 Mar 2022 | Canada
Soundly Predicted, But Not Obvious: Validity Of MS Drug Patent Upheld On Appeal
09 Feb 2022 | Canada
Federal Court Finds Minister Of Health's Refusal Of BELSOMRA CSP Unreasonable, Remits For Redetermination
24 Nov 2021 | Canada
Canadian Drug Price Review Board Reined In
06 Aug 2021 | Canada
Canadian Drug Price Review Of Generic Companies Holding Patents
08 Oct 2019 | Canada
While Americans Laud "Low" Canadian Drug Prices, Canadian Innovative Pharma Waits To See If The Pricing Axe Will Fall On "Excessive" Canadian Drug Prices
09 Aug 2019 | Canada
Contact Details
Toronto
Scotia Plaza, 40 King Street West
40th Floor
Toronto Ontario M5H 3Y2
Canada
Telephone: 1-416-3647311

  © Mondaq® Ltd 1994 - 2023. All Rights Reserved.